The Prognostic and Predictive Value of Excision Repair Cross-Complementation Group 1 (ERCC1) Protein in 1288 Patients With Head and Neck Squamous Cell Carcinoma Treated With Platinum-Based Therapy: A Meta-Analysis
European Archives of Oto-Rhino-Laryngology - Germany
doi 10.1007/s00405-015-3710-x
Full Text
Open PDFAbstract
Available in full text
Date
July 16, 2015
Authors
Publisher
Springer Science and Business Media LLC